#cellsearch search results
Excited to be speaking at the CellSearch DEPArray User Meeting in Philly! #Menarini #CellSearch #CTCs @EricDonnellyMD @MCristofanill
#CTC at #ESMObreast24 part3: the complete workflow of #CellSearch + #DEPArray (all tools by Menarini Silicon Biosystems: we are at booth #30, come to visit us!) allows molecular DNA analysis for intra patient heterogeneity (yes in the pic is a melanoma patient, but works anyway)
Excited about the novel #liquidbiopsy insights at the #CellSearch and #DEPArray user meeting in Philadelphia @SiliconBio @deparray
In new study, authors evaluated the diagnostic value of circulating tumor cell detection in CSF using #CellSearch for the diagnosis of #breastcancer related leptomeningeal metastases, compared with conventional cytology. Link: buff.ly/3D6yniz #PathTwitter #Oncology
21 studies at #SABCS18 featuring #CTC testing with #CellSearch, the 1st and only FDA-cleared blood test for detecting and enumerating CTCs to aid in #MBC patient management. Visit @siliconbio at Booth 413 to learn more. #liquidbiopsy #genomics bit.ly/2Rlc7qN
RT LizDowling2 "21 studies at #SABCS18 featuring #CTC testing with #CellSearch, the 1st and only FDA-cleared blood test for detecting and enumerating CTCs to aid in #MBC patient management. Visit siliconbio at Booth 413 to learn more. #liquidbiopsy #… https://t.co/kP6ppH2tPK"
RT LizDowling2 "Attending #SABCS18? 20 studies investigating the clinical utility of #CellSearch, the 1st and only FDA-cleared blood test for detecting and enumerating CTCs to aid in #MBC #breastcancer patient management. Visit siliconbio at Booth 4… https://t.co/VmN9SleygM"
Live at #SABCS19! Stop by Booth 909 to learn more about the value of #CellSearch and #CTCs enumeration in #metastaticbreastcancer. Discover our entire worflow for cell-based #liquidbiopsy
K9 Armo #cellsearch #working #BluePawsMatter 🐾🚔 💙 @GwinnettSOK9 #CottonandArmo
We are looking forward to connecting with old friends and colleagues while meeting new ones as well at the upcoming #AACR23 Annual meeting. Be sure to stop by our booth (#100) to learn how #CELLSEARCH and #DEPArray PLUS can enhance your #cancerresearch.
Lopes, V., Degardin, B., Alexandre, L.A. published the paper "Are neural architecture search benchmarks well designed? A deeper look into operation importance" in Information Sciences. Doi: 10.1016/j.ins.2023.119695 #AutoML #Benchmarks #Cellsearch #Convolutionalneuralnetworks
Flow-based immunomagnetic enrichment of circulating tumor cells from diagnostic leukapheresis product 🔗buff.ly/47JmuuT #Leukapheresis #CellSearch #PCSM #Camoldx #Cactc @JWMMartens
The STIC CTC trial (lnkd.in/dHrRWdz9) shows that using CTC count as a tool to choose between ET and CT is non-inferior to the investigator's choice in terms of short and long-term clinical outcomes. #CTC #LiquidBiopsy #CellSearch #ClinicalUtility prn.to/3SnPjsI
prnewswire.com
CELLSEARCH® CTC count proves its clinical utility in guiding therapeutic strategy supporting...
STIC CTC trial data published this November 2023 in the Journal of Clinical Oncology (JCO) demonstrate that CTC-guided treatment decision confers superior...
Register for our next coffee chat "EpCAM low CTC Success with CELLSEARCH" on Friday June 18, 11 AM Eastern Standard Time/ 5 PM Central European Time. Register here: bit.ly/3pWARHX #CELLSEARCH, #EpCAM, #Ferrofluid
We are attending ESMO Congress 2021 as Bronze Exhibitor! Visit our virtual space to discover the CELLSEARCH Circulating Tumor Cell Test. For full intended use visit: bit.ly/3AnsOZh #CELLSEARCH, #CTC, #ESMO21
📢News Release: "New CELLSEARCH® Circulating Multiple Myeloma Test now available to help community physicians optimize patient care" Read the full press release: prn.to/3xBk5lM #CELLSEARCH #LDT #MultipleMyeloma #CLIALab
New data presented at the 2021 EULAR Congress shows that CELLSEARCH CEC assay may provide reliable and reproducible CEC count to monitor systemic sclerosis in clinical research studies. Read the full press release bit.ly/2TRf3lr #EULAR21, #SystemicSclerosis, #CELLSEARCH
Circulating Tumor Cell detection by Menarini Group’s CELLSEARCH® System leading to genomic profiling of myeloma cells shows potential for non-invasive management of #MultipleMyeloma patients at early stages of disease Full press release menarini.com/en-us/news/new… #ctc #CELLSEARCH
#CTC at #ESMObreast24 part3: the complete workflow of #CellSearch + #DEPArray (all tools by Menarini Silicon Biosystems: we are at booth #30, come to visit us!) allows molecular DNA analysis for intra patient heterogeneity (yes in the pic is a melanoma patient, but works anyway)
Flow-based immunomagnetic enrichment of circulating tumor cells from diagnostic leukapheresis product 🔗buff.ly/47JmuuT #Leukapheresis #CellSearch #PCSM #Camoldx #Cactc @JWMMartens
The STIC CTC trial (lnkd.in/dHrRWdz9) shows that using CTC count as a tool to choose between ET and CT is non-inferior to the investigator's choice in terms of short and long-term clinical outcomes. #CTC #LiquidBiopsy #CellSearch #ClinicalUtility prn.to/3SnPjsI
prnewswire.com
CELLSEARCH® CTC count proves its clinical utility in guiding therapeutic strategy supporting...
STIC CTC trial data published this November 2023 in the Journal of Clinical Oncology (JCO) demonstrate that CTC-guided treatment decision confers superior...
Lopes, V., Degardin, B., Alexandre, L.A. published the paper "Are neural architecture search benchmarks well designed? A deeper look into operation importance" in Information Sciences. Doi: 10.1016/j.ins.2023.119695 #AutoML #Benchmarks #Cellsearch #Convolutionalneuralnetworks
#MenariniSiliconBiosystems new #CELLSEARCH data presented at #AACR23 highlights trailblazing contributions of #LiquidBiopsies for #Cancer research 1stoncology.com/blog/menarini-…
We are looking forward to connecting with old friends and colleagues while meeting new ones as well at the upcoming #AACR23 Annual meeting. Be sure to stop by our booth (#100) to learn how #CELLSEARCH and #DEPArray PLUS can enhance your #cancerresearch.
#MenariniSilicon reported New STIC trial data shows longer overall survival for therapy selection based on #CELLSEARCH® CTC count in patients with metastatic #BreastCancer 1stoncology.com/blog/new-stic-…
Circulating Tumor Cell detection by Menarini Group’s CELLSEARCH® System leading to genomic profiling of myeloma cells shows potential for non-invasive management of #MultipleMyeloma patients at early stages of disease Full press release menarini.com/en-us/news/new… #ctc #CELLSEARCH
In new study, authors evaluated the diagnostic value of circulating tumor cell detection in CSF using #CellSearch for the diagnosis of #breastcancer related leptomeningeal metastases, compared with conventional cytology. Link: buff.ly/3D6yniz #PathTwitter #Oncology
#MenariniSiliconBiosystems Announces Study Results Presented at #ASH21 Annual Meeting Highlighting #CELLSEARCH #CMMC assay, a Non-Invasive #LiquidBiopsy for the Quantification and #Molecular Characterization of Circulating #MultipleMyeloma Cells 1stoncology.com/blog/menarini-…
📢News Release: "New CELLSEARCH® Circulating Multiple Myeloma Test now available to help community physicians optimize patient care" Read the full press release: prn.to/3xBk5lM #CELLSEARCH #LDT #MultipleMyeloma #CLIALab
We are attending ESMO Congress 2021 as Bronze Exhibitor! Visit our virtual space to discover the CELLSEARCH Circulating Tumor Cell Test. For full intended use visit: bit.ly/3AnsOZh #CELLSEARCH, #CTC, #ESMO21
Check out the presentation by Dr Jaco Kraan, PhD "The Rotterdam experiences", sharing insights on his experience using CELLSEARCH 4th open channel. Watch it now on our YouTube channel bit.ly/3E4nXOM #CellSearch, #CTC, #characterization, #4thChannel, #webinar
Check out the presentation "CTC Characterization using CellSearch: Beyond Enumeration" by Dr Daniel F. Hayes, MD, FASCO, FACP You can watch it any time on our YouTube channel bit.ly/3zjtVIN #CellSearch, #CTC, #characterization, #4thChannel, #webinar
Check out the presentation by Dr Paolo D'Amico, MD "The cHER2 ratio (circulating HER2 ratio): implementing a novel biomarker to define the role of HER2+ CTC in metasttic breast cancer" bit.ly/2Vv7D82 #CellSearch, #CTC, #characterization, #4thChannel, #webinar
Watch the recording of our Coffee Chat "EpCAM low Circulating Tumor Cell Success with CELLSEARCH" to learn how our ferrofluid works with rare antigens in low-expression target cells. Watch it now bit.ly/3i2wA2b #EpCAM, #CTC, #CellSearch
Excited about the novel #liquidbiopsy insights at the #CellSearch and #DEPArray user meeting in Philadelphia @SiliconBio @deparray
Excited to be speaking at the CellSearch DEPArray User Meeting in Philly! #Menarini #CellSearch #CTCs @EricDonnellyMD @MCristofanill
21 studies at #SABCS18 featuring #CTC testing with #CellSearch, the 1st and only FDA-cleared blood test for detecting and enumerating CTCs to aid in #MBC patient management. Visit @siliconbio at Booth 413 to learn more. #liquidbiopsy #genomics bit.ly/2Rlc7qN
In new study, authors evaluated the diagnostic value of circulating tumor cell detection in CSF using #CellSearch for the diagnosis of #breastcancer related leptomeningeal metastases, compared with conventional cytology. Link: buff.ly/3D6yniz #PathTwitter #Oncology
Last chance to discover our cell-based #LiquidBiopsy workflow with #CELLSEARCH & #DEPArray Visit us at booth 601 #TRICON #SingleCell
Flow-based immunomagnetic enrichment of circulating tumor cells from diagnostic leukapheresis product 🔗buff.ly/47JmuuT #Leukapheresis #CellSearch #PCSM #Camoldx #Cactc @JWMMartens
Single-cells genome-wide #copy-number profiling by low-pass sequencing with our #CELLSEARCH + #DEPArray + #Ampli1 workflow. Come to booth 3107 #ASCO18 to get a copy of our #PLOSONE publication
Discover the value of #CELLSEARCH + #DEPArray systems integration for liquid biopsy in cancer research - beyond cell enumeration Stop by booth 1426 #AACR18 exhibit hall
Attending #ASCO2019? Check out new data on #CellSearch and isolating #circulatingtumorcells in patients with #metastatic #breastcancer. #liquidbiopsy #CTCs. Visit us at Booth 4111 to learn more!
Good morning Chicago! It's our last day at #ASCO18. Come learn how #CELLSEARCH & #DEPArray deliver precision in #SingleCell isolation from #LiquidBiopsy Booth 3107
#CTC at #ESMObreast24 part3: the complete workflow of #CellSearch + #DEPArray (all tools by Menarini Silicon Biosystems: we are at booth #30, come to visit us!) allows molecular DNA analysis for intra patient heterogeneity (yes in the pic is a melanoma patient, but works anyway)
#ASCO18 exhibits are open! Stop by booth 3107 to learn how #CELLSEARCH & #DEPArray can isolate #SingleCell for molecular characterization of #CTCs in liquid biopsy
RT LizDowling2 "Attending #SABCS18? 20 studies investigating the clinical utility of #CellSearch, the 1st and only FDA-cleared blood test for detecting and enumerating CTCs to aid in #MBC #breastcancer patient management. Visit siliconbio at Booth 4… https://t.co/VmN9SleygM"
RT LizDowling2 "21 studies at #SABCS18 featuring #CTC testing with #CellSearch, the 1st and only FDA-cleared blood test for detecting and enumerating CTCs to aid in #MBC patient management. Visit siliconbio at Booth 413 to learn more. #liquidbiopsy #… https://t.co/kP6ppH2tPK"
#AACR18 exhibits are open! Stop by booth 1426 to learn how #CELLSEARCH + #DEPArray NxT can isolate #SingleCell for molecular characterization of #CTCs in liquid biopsy
Come to discover our end-to-end workflow solution with #CELLSEARCH & #DEPArray for the enumeration, isolation, and molecular characterization of #CTCs in clincial #cancer research Booth 3107 #ASCO18
Live at #SABCS19! Stop by Booth 909 to learn more about the value of #CellSearch and #CTCs enumeration in #metastaticbreastcancer. Discover our entire worflow for cell-based #liquidbiopsy
Come to meet us at #TRICON booth 601 Discover our sample-to-result, #LiquidBiopsy workflow with #CELLSEARCH #DEPArray Ampli1 LowPass WGS for Copy Number Aberrations analysis on single CTCs
#Single-cells genome-wide #copy-number profiling by low-pass sequencing with our #CELLSEARCH + #DEPArray + Ampli1 workflow - for a comprehensive molecular profiling of rare cells. Come to booth 311 to learn more #ESMO19 #RareCells
Something went wrong.
Something went wrong.
United States Trends
- 1. Texas A&M 13.6K posts
- 2. South Carolina 13.3K posts
- 3. Marcel Reed 2,648 posts
- 4. Aggies 3,983 posts
- 5. Nyck Harbor 1,451 posts
- 6. College Station 2,071 posts
- 7. Elko 2,467 posts
- 8. Jeremiyah Love 3,250 posts
- 9. Malachi Fields 1,464 posts
- 10. Mike Shula N/A
- 11. Dylan Stewart N/A
- 12. Shane Beamer N/A
- 13. TAMU 5,727 posts
- 14. Michigan 39.6K posts
- 15. #GoIrish 3,034 posts
- 16. Sellers 9,625 posts
- 17. Northwestern 4,242 posts
- 18. Randy Bond N/A
- 19. Sherrone Moore N/A
- 20. Zvada N/A